Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL258805 (Su-9516, Su9516, SU-9516) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
cyclin dependent kinase 2/CDK2/Cyclin A2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3038469] [GtoPdb: 1973] [UniProtKB: P20248, P24941] | ||||||||
ChEMBL | Inhibition of GST-tagged CDK2/cyclin A2 (unknown origin) expressed in Escherichia coli using histone H1 as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay | B | 7.57 | pIC50 | 27 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
GtoPdb | In vitro inhibition of CDK2/cyclin A. | - | 7.57 | pIC50 | 27 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
GtoPdb | In vitro inhibition of CDK2/cyclin E. | - | 7.59 | pIC50 | 26 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
GtoPdb | CDK2/cyclin A complex used in assay | - | 7.66 | pIC50 | 22 | nM | IC50 | Cancer Res (2001) 61: 6170-7 [PMID:11507069] |
cyclin dependent kinase 7/CDK7/Cyclin H/MNAT1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3038473] [GtoPdb: 1979] [UniProtKB: P50613, P51946, P51948] | ||||||||
GtoPdb | In vitro inhibition of CDK7/cyclin H. | - | 6.04 | pIC50 | 905 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
ChEMBL | Inhibition of GST-tagged CDK7/cyclinH/MAT1 (unknown origin) expressed in Baculovirus infected Sf9 cells using YSPTSPS-2 KK peptide as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay | B | 6.04 | pIC50 | 905 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
cyclin dependent kinase 9/CDK9/cyclin T1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111389] [GtoPdb: 1981] [UniProtKB: O60563, P50750] | ||||||||
GtoPdb | In vitro inhibition of CDK9/cyclin T. | - | 5.82 | pIC50 | 1500 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
ChEMBL | Inhibition of GST-tagged CDK9/CyclinT1 (unknown origin) expressed in Baculovirus infected Sf9 cells using YSPTSPS-2 KK peptide as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay | B | 5.82 | pIC50 | 1500 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
cyclin dependent kinase 1/Cyclin-dependent kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL308] [GtoPdb: 1961] [UniProtKB: P06493] | ||||||||
GtoPdb | In vitro inhibition of CDK1/cyclin B. | - | 6.77 | pIC50 | 168 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
ChEMBL | Inhibition of CDK1 | B | 7.26 | pIC50 | 55 | nM | IC50 | AAPS J (2006) 8: E204-E221 [PMID:16584130] |
ChEMBL | Inhibition of His-6-tagged CDK1 (unknown origin) expressed in baculovirus-infected insect cells using histone H1 as substrate after 1 hr by by liquid scintillation counting in presence of [gamma-33P]ATP | B | 7.4 | pIC50 | 40 | nM | IC50 | J Med Chem (2014) 57: 578-599 [PMID:24417566] |
GtoPdb | CDK1/cyclin B complex used in assay | - | 7.4 | pIC50 | 40 | nM | IC50 | Cancer Res (2001) 61: 6170-7 [PMID:11507069] |
cyclin dependent kinase 1/Cyclin-dependent kinase 1/cyclin B in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2094127] [GtoPdb: 1961] [UniProtKB: O95067, P06493, P14635, Q8WWL7] | ||||||||
GtoPdb | In vitro inhibition of CDK1/cyclin B. | - | 6.77 | pIC50 | 168 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
GtoPdb | CDK1/cyclin B complex used in assay | - | 7.4 | pIC50 | 40 | nM | IC50 | Cancer Res (2001) 61: 6170-7 [PMID:11507069] |
ChEMBL | Inhibition of CDK1/cyclinB | B | 7.66 | pIC50 | 22 | nM | IC50 | Trends Pharmacol Sci (2004) 25: 471-480 [PMID:15559249] |
cyclin dependent kinase 1/Cyclin-dependent kinase 1/cyclin B1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907602] [GtoPdb: 1961] [UniProtKB: P06493, P14635] | ||||||||
GtoPdb | In vitro inhibition of CDK1/cyclin B. | - | 6.77 | pIC50 | 168 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
ChEMBL | Inhibition of His-tagged CDK1/cyclin B1 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay | B | 6.77 | pIC50 | 168 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
GtoPdb | CDK1/cyclin B complex used in assay | - | 7.4 | pIC50 | 40 | nM | IC50 | Cancer Res (2001) 61: 6170-7 [PMID:11507069] |
cyclin dependent kinase 2/Cyclin-dependent kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL301] [GtoPdb: 1973] [UniProtKB: P24941] | ||||||||
ChEMBL | Inhibitory activity against Cyclin-dependent kinase 2 | B | 6.96 | pIC50 | 110 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1939-1942 [PMID:12749903] |
ChEMBL | Inhibition of CDK2 | B | 7.46 | pIC50 | 35 | nM | IC50 | AAPS J (2006) 8: E204-E221 [PMID:16584130] |
GtoPdb | In vitro inhibition of CDK2/cyclin A. | - | 7.57 | pIC50 | 27 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
GtoPdb | In vitro inhibition of CDK2/cyclin E. | - | 7.59 | pIC50 | 26 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
ChEMBL | Inhibition of His-6-tagged CDK2 (unknown origin) expressed in baculovirus-infected insect cells using histone H1 as substrate after 1 hr by by liquid scintillation counting in presence of [gamma-33P]ATP | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2014) 57: 578-599 [PMID:24417566] |
GtoPdb | CDK2/cyclin A complex used in assay | - | 7.66 | pIC50 | 22 | nM | IC50 | Cancer Res (2001) 61: 6170-7 [PMID:11507069] |
cyclin dependent kinase 2/Cyclin-dependent kinase 2/cyclin E1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907605] [GtoPdb: 1973] [UniProtKB: P24864, P24941] | ||||||||
GtoPdb | In vitro inhibition of CDK2/cyclin A. | - | 7.57 | pIC50 | 27 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
ChEMBL | Inhibition of His-tagged CDK2/cyclin E (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay | B | 7.59 | pIC50 | 26 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
GtoPdb | In vitro inhibition of CDK2/cyclin E. | - | 7.59 | pIC50 | 26 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
GtoPdb | CDK2/cyclin A complex used in assay | - | 7.66 | pIC50 | 22 | nM | IC50 | Cancer Res (2001) 61: 6170-7 [PMID:11507069] |
cyclin dependent kinase 4/Cyclin-dependent kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL331] [GtoPdb: 1976] [UniProtKB: P11802] | ||||||||
GtoPdb | In vitro inhibition of CDK4/cyclin D. | - | 5.77 | pIC50 | 1700 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
ChEMBL | Inhibition of CDK4 | B | 6.52 | pIC50 | 300 | nM | IC50 | AAPS J (2006) 8: E204-E221 [PMID:16584130] |
ChEMBL | Inhibition of His-6-tagged CDK4 (unknown origin) expressed in baculovirus-infected insect cells using GST-retinoblastoma as substrate after 1 hr by by liquid scintillation counting in presence of [gamma-33P]ATP | B | 6.7 | pIC50 | 200 | nM | IC50 | J Med Chem (2014) 57: 578-599 [PMID:24417566] |
GtoPdb | CDK4/cyclin D1 complex used in assay | - | 6.7 | pIC50 | 200 | nM | IC50 | Cancer Res (2001) 61: 6170-7 [PMID:11507069] |
cyclin dependent kinase 4/Cyclin-dependent kinase 4/cyclin D1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907601] [GtoPdb: 1976] [UniProtKB: P11802, P24385] | ||||||||
ChEMBL | Inhibition of GST-tagged CDK4/cyclin D1 (unknown origin) expressed in Baculovirus infected Sf9 cells using RPPTLSPIPHIPR peptide as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay | B | 5.77 | pIC50 | 1700 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
GtoPdb | In vitro inhibition of CDK4/cyclin D. | - | 5.77 | pIC50 | 1700 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
GtoPdb | CDK4/cyclin D1 complex used in assay | - | 6.7 | pIC50 | 200 | nM | IC50 | Cancer Res (2001) 61: 6170-7 [PMID:11507069] |
cyclin dependent kinase 5/Cyclin-dependent kinase 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4036] [GtoPdb: 1977] [UniProtKB: Q00535] | ||||||||
ChEMBL | Inhibition of CDK5 | B | 7.19 | pIC50 | 65 | nM | IC50 | AAPS J (2006) 8: E204-E221 [PMID:16584130] |
GtoPdb | In vitro inhibition of CDK5/p25. | - | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
cyclin dependent kinase 5/Cyclin-dependent kinase 5/CDK5 activator 1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907600] [GtoPdb: 1977] [UniProtKB: Q00535, Q15078] | ||||||||
ChEMBL | Inhibition of GST-tagged CDK5/p25 (unknown origin) expressed in Baculovirus infected Sf9 cells using histone H1 as substrate as substrate in presence of [gamma-33P]-ATP by radiometric filter binding assay | B | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
GtoPdb | In vitro inhibition of CDK5/p25. | - | 7.66 | pIC50 | 22 | nM | IC50 | J Med Chem (2018) 61: 9105-9120 [PMID:30234987] |
epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
ChEMBL | Inhibition of EGFR | B | 5 | pIC50 | >10000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
eukaryotic translation initiation factor 2 alpha kinase 2/Interferon-induced, double-stranded RNA-activated protein kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5785] [GtoPdb: 2016] [UniProtKB: P19525] | ||||||||
ChEMBL | Inhibition of human recombinant PKR autophosphorylation using poly[I:C] after 10 mins by luminescent assay | B | 5.3 | pIC50 | 5000 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 4108-4114 [PMID:21632247] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay | F | 4.9 | pIC50 | 12589.25 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay | F | 5 | pIC50 | 10000 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay | F | 5.1 | pIC50 | 7943.28 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay | F | 5.1 | pIC50 | 7943.28 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay | F | 5.2 | pIC50 | 6309.57 | nM | IC50 | Nat Chem Biol (2009) 5: 765-771 [PMID:19734910] |
platelet derived growth factor receptor beta/Platelet-derived growth factor receptor beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1913] [GtoPdb: 1804] [UniProtKB: P09619] | ||||||||
ChEMBL | Inhibitory activity was tested against Platelet-derived growth factor receptor beta | B | 4.74 | pIC50 | 18000 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1939-1942 [PMID:12749903] |
ChEMBL | Inhibition of PDGFRbeta | B | 5 | pIC50 | >10000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
ret proto-oncogene/Tyrosine-protein kinase receptor RET in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2041] [GtoPdb: 2185] [UniProtKB: P07949] | ||||||||
ChEMBL | Inhibition of human recombinant His-tagged RET expressed in Sf9 insect cells | B | 5.8 | pIC50 | 1600 | nM | IC50 | Bioorg Med Chem (2010) 18: 1482-1496 [PMID:20117004] |
SRC proto-oncogene, non-receptor tyrosine kinase/Tyrosine-protein kinase SRC in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL267] [GtoPdb: 2206] [UniProtKB: P12931] | ||||||||
ChEMBL | Inhibitory activity was tested against Src protein tyrosine kinase | B | 4.96 | pIC50 | 11000 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1939-1942 [PMID:12749903] |
kinase insert domain receptor/Vascular endothelial growth factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL279] [GtoPdb: 1813] [UniProtKB: P35968] | ||||||||
ChEMBL | Inhibitory activity was tested against FLK kinase | B | 6.89 | pIC50 | 130 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1939-1942 [PMID:12749903] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]